Alder Signs Billion Dollar Deal with Bristol-Myers Squibb
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 11 (Table of Contents)
Published: 17 Nov-2009
DOI: 10.3833/pdr.v2009.i11.1273 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Bristol-Myers Squibb has acquired rights to a monoclonal antibody for treating rheumatoid arthritis from Alder Biopharmaceuticals in deal that could exceed US$1 B...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018